| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/08/1995 | CA2177953A1 Plant arabinogalactan protein (agp) genes |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177367A1 Recombinant binding proteins and peptides |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/07/1995 | EP0656419A1 Method of highly purifying human serum albumin |
| 06/07/1995 | EP0656121A1 Method for diagnosing and monitoring sepsis |
| 06/07/1995 | EP0656114A1 Method of determining metastatic potential of tumor cells |
| 06/07/1995 | EP0656069A1 Inhibitors of cell proliferation, their preparation and use |
| 06/07/1995 | EP0656062A1 Dorsal tissue affecting factor and compositions |
| 06/07/1995 | EP0656061A1 Novel glycoforms of soluble complement receptor 1 |
| 06/07/1995 | EP0656060A1 Androgen regulation with dna sequences of rat probasin gene |
| 06/07/1995 | EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 06/07/1995 | EP0656012A1 T cell epitopes of ryegrass pollen allergen |
| 06/07/1995 | EP0656007A1 Opioid receptor genes |
| 06/07/1995 | EP0655924A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 06/07/1995 | EP0655888A1 Production of human hemoglobin in transgenic pigs |
| 06/07/1995 | EP0578754B1 TrpR MUTATIONS EFFECTIVE IN THE EXPRESSION OF SMALL PROTEINS AND PEPTIDES |
| 06/07/1995 | EP0462277B1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | EP0330655B1 Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor |
| 06/07/1995 | CN1103404A Novel monoclonal antibodies recognizing the epidermal growth factor-receptor, cells and methods for producing them and compositions containing them |
| 06/06/1995 | US5422424 Antibiotic cryptdin peptides and methods of their use |
| 06/06/1995 | US5422274 Internal deletion mutants of soluble T4(CD4) |
| 06/06/1995 | US5422265 Provides nucleotide sequence encoding mammalian dopamine receptor having drug dissociation properties of the human dopamine receptor d4 |
| 06/06/1995 | US5422264 Harvesting protein medium secreted by rat bladder carcinoma cells, then culturing epithelial cells in medium |
| 06/06/1995 | US5422263 DNA encoding the Trichinella spirals 53kD excretory/secretory antigen for use as immunodiagnostic reagents |
| 06/06/1995 | US5422250 Including in the culture medium a sulfated polysaccharide |
| 06/06/1995 | US5422249 Process for the manufacture of thrombin inhibitors |
| 06/06/1995 | US5422104 TNF-muteins |
| 06/06/1995 | US5421839 Fermentatiion of aspergillus giganteus |
| 06/06/1995 | CA1335802C O-glycosylated igf-1 |
| 06/06/1995 | CA1335800C Synovial phospholipases |
| 06/06/1995 | CA1335798C Retroviral vector |
| 06/06/1995 | CA1335796C Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
| 06/01/1995 | WO1995014780A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| 06/01/1995 | WO1995014778A2 Dna sequence coding for a bmp receptor |
| 06/01/1995 | WO1995014776A1 PROTEIN TYROSINE KINASES NAMED Rse |
| 06/01/1995 | WO1995014775A1 Translational enhancer dna |
| 06/01/1995 | WO1995007353A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 06/01/1995 | WO1995006732A3 Bacterial exported proteins and acellular vaccines based thereon |
| 06/01/1995 | WO1994025598A3 Methods and compositions for salmonella-based vaccines |
| 06/01/1995 | CA2174863A1 Translational enhancer dna |
| 05/31/1995 | EP0655626A1 Diagnostic assays for Alzheimer's disease |
| 05/31/1995 | EP0655499A1 A novel gene encoding phytolacca antiviral protein |
| 05/31/1995 | EP0655162A1 Compositions of bacteriorhodopsin variants with increased memory time and their use |
| 05/31/1995 | EP0655088A1 Oligonucleotides having chiral phosphorus linkages |
| 05/31/1995 | EP0401369B1 Method for preparative expression of genes in a cell-free system of conjugated transcription/translation |
| 05/31/1995 | EP0375724B1 Biologically active bactericidal/permeability-increasing protein fragments |
| 05/31/1995 | EP0372019B1 RHOPTRY MEMBRANE ANTIGEN OF $i(PLASMODIUM FALCIPARUM) |
| 05/30/1995 | US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof |
| 05/30/1995 | US5420252 For treatment of thrombotic disorders |
| 05/30/1995 | US5420247 Genetic engineering and expression vectors |
| 05/30/1995 | US5420030 Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof |
| 05/30/1995 | US5420028 Truncated human cholesterol 7α-hydroxylase, method of production and use thereof |
| 05/30/1995 | US5420026 Self-assembling replication defective hybrid virus particles |
| 05/30/1995 | US5420019 Stable bactericidal/permeability-increasing protein muteins |
| 05/30/1995 | US5419904 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/30/1995 | US5419899 Purified, reduced recombinant interleukin-2 compositions |
| 05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
| 05/30/1995 | CA1335719C Efficient process for producing active chymosin from a precursor protein synthesized in bacteria |
| 05/30/1995 | CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 05/26/1995 | WO1995014233A2 Method of identifying hdm-2-specific antibodies |
| 05/26/1995 | WO1995014099A2 Process for protein production in plants |
| 05/26/1995 | WO1995014093A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 05/26/1995 | WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | WO1995014082A1 Delivery of gene products via mesangial cells |
| 05/26/1995 | WO1995014042A1 Antihuman tyrosinase monoclonal antibody |
| 05/26/1995 | WO1995014041A1 Reconstituted human antibody against human medulloblastomatous cell |
| 05/26/1995 | WO1995014038A2 Purification of hemoglobin |
| 05/26/1995 | WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 05/26/1995 | WO1995013823A1 Method of treating neurological disorders |
| 05/26/1995 | WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
| 05/26/1995 | WO1995013701A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | WO1995013697A1 Hepatoblasts and method of isolating same |
| 05/26/1995 | WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/26/1995 | CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 05/26/1995 | CA2176708A1 Method of treating neurological disorders |
| 05/26/1995 | CA2176575A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | CA2153482A1 Delivery of gene products via mesangial cells |
| 05/24/1995 | EP0654532A1 Antimucoglycoprotein monoclonal antibody |
| 05/24/1995 | EP0654530A2 Ubiquitin carrier enzyme E2-F1, purification, production and use |
| 05/24/1995 | EP0654144A1 Immunochemical assays for cancer-associated scm recognition factor |
| 05/24/1995 | EP0654092A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 05/24/1995 | EP0654083A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 05/24/1995 | EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 05/24/1995 | EP0653940A1 Glial mitogenic factors, their preparation and use |
| 05/24/1995 | EP0604560A4 Human cyclin e. |
| 05/24/1995 | EP0574394B1 Substances of polypeptide nature useful in human therapy |
| 05/24/1995 | EP0398997B1 Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses |
| 05/24/1995 | EP0357767B1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
| 05/24/1995 | CN1102859A Process for making zymolysis ovalbumin |
| 05/24/1995 | CA2135587A1 Antitumor antibiotics |
| 05/23/1995 | US5418221 Composition containing enamel matrix from tooth germs for inducing binding between living mineralized tissue parts |
| 05/23/1995 | US5418159 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 05/23/1995 | US5418153 Brome mosaic virus |
| 05/23/1995 | US5418147 Glycosyl-phosphatidylinositol-specific phospholipase D |
| 05/23/1995 | US5418146 Process for preparing dipeptides |
| 05/23/1995 | US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists |